Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

CYP2D6*4 allele polymorphism increases the risk of Parkinson's disease: evidence from meta-analysis.

PloS one - 1 Jan 2013

Lu Yu, Mo Cuiju, Zeng Zhiyu, Chen Siyuan, Xie Yantong, Peng Qiliu, He Yu, Deng Yan, Wang Jian, Xie Li, Zeng Jie, Li Shan, Qin Xue

Abstract excerpt

BACKGROUND: Many epidemiological studies have been conducted to explore the association between a single CYP2D6 gene polymorphism and Parkinson's disease (PD) susceptibility. However, the results remain controversial. OBJECTIVES: To clarify the effects of a single CYP2D6 gene polymorphism on the risk of PD, a meta-analysis of all available studies relating to CYP2D6*4 polymorphism and the risk of PD was...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cytochrome P-450 CYP2D6
Share to Genetic Heterogeneity

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Odds Ratio

Share to Parkinson Disease

Share to Polymorphism, Single Nucleotide

Share to Regression Analysis

Share to Sensitivity and Specificity

Share to White People

Source

Open in PubMed Open full text

Identifiers

PMID: 24376807
DOI: 10.1371/journal.pone.0084413
PMCID: PMC3869836

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

CYP2D6*4 allele polymorphism increases the risk of Parkinson's disease: evidence from meta-analysis.PMID 24376807Read ↗

CYP2D6 phenotypes and Parkinson's disease risk: a meta-analysis.Semantic proximity Read ↗

Cytochrome P450 2D6 and Parkinson's Disease: Polymorphism, Metabolic Role, Risk and Protection.Semantic proximity Read ↗

Parkinson's disease and CYP2D6 polymorphism in Asian populations: A meta-analysis.Semantic proximity Read ↗

Further evidence for the association of CYP2D6*4 gene polymorphism with Parkinson’s disease: a case control studySemantic proximity Read ↗

CYP2D6 polymorphism in Parkinson's disease: the Rotterdam Study.Semantic proximity Read ↗

Quantitative assessment of CYP2D6 polymorphisms and risk of Alzheimer's disease: a meta-analysis.Semantic proximity Read ↗

Methylenetetrahydrofolate reductase (MTHFR) C677T/A1298C polymorphisms and susceptibility to Parkinson's disease: a meta-analysis.Semantic proximity Read ↗

The relationship between monoamine oxidase B (MAOB) A644G polymorphism and Parkinson disease risk: a meta-analysis.Semantic proximity Read ↗

Vitamin D deficiency and genetic polymorphisms of Vitamin D-associated genes in Parkinson's DiseaseSemantic proximity Read ↗

Genotyping of CYP2D6 in Parkinson's disease.Semantic proximity Read ↗

Vitamin D deficiency and genetic polymorphisms of vitamin D-associated genes in Parkinson's disease.Semantic proximity Read ↗

Roles of gender, age at onset and environmental risk in the frequency of CYP2D6-deficient alleles in patients with Parkinson's disease.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.